Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Detection of Peripheral Neuropathy in Hereditary Transthyretin Amyloidosis

NCT05311488 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT05311488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05311488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Detection of Peripheral Neuropathy in Hereditary Transthyretin Amyloidosis
Lead sponsor
University of Pennsylvania
Phase
Observational
Overall status
Completed
Start date
February 14, 2022
Completion date
February 14, 2026
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary amyloidosis, transthyretin-related